Last updated: July 06, 2026

Application No. 19/363,300

Untitled Application

Unknown

Filed

Priority

Oct 17, 2013 — provisional 61/892,372 +5 more

Examiner

LU, FRANK WEI MIN

Art Unit

Tech Center

Takara Bio USA, Inc.

Assignee

Takara Bio Usa Inc.

OA Round

1 (Non-Final)

Interview Optional

— +67.1% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 63% grant rate with +67.1% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 695 resolved cases, 2023–2026

Examiner Intelligence

LU, FRANK WEI MIN View full profile →

Grants 63% of resolved cases

Career Allowance Rate

437 granted / 695 resolved

+2.9% vs TC avg

Strong +67% interview lift

Without

With

+67.1%

Interview Lift

resolved cases with interview

Typical timeline

4y 1m

Avg Prosecution

41 currently pending

Career history

759

Total Applications

across all art units

Statute-Specific Performance

§101

1.0%

-39.0% vs TC avg

§103

34.6%

-5.4% vs TC avg

§102

5.6%

-34.4% vs TC avg

§112

43.9%

+3.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 695 resolved cases

Prosecution Timeline

Mar 24, 2026

Examiner Interview (Telephonic)

Apr 30, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/972,253

Patent 12668841

IN SITU SEQUENCING OF RNA TRANSCRIPTS WITH NON-UNIFORM 5' ENDS

1y 6m to grant Granted Jun 30, 2026

17/487,610

Patent 12649953

PAPER-BASED SYNTHETIC GENE NETWORKS

4y 8m to grant Granted Jun 09, 2026

17/757,140

Patent 12644114

IN VITRO RAPID SYNTHESIS OF MEDIUM-AND HIGH-COPY DNA REPEATS BASED ON BLOCKING POLYMERASE CHAIN REACTION

3y 11m to grant Granted Jun 02, 2026

16/904,529

Patent 12606815

SELF-DIVERSIFYING SYSTEMS AND METHODS OF USE THEREOF

5y 10m to grant Granted Apr 21, 2026

16/982,135

Patent 12595476

ASSEMBLY AND ERROR REDUCTION OF SYNTHETIC GENES FROM OLIGONUCLEOTIDES

5y 6m to grant Granted Apr 07, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

63%

Grant Probability

99%

With Interview (+67.1%)

4y 1m

Median Time to Grant

Low

PTA Risk

Based on 695 resolved cases by this examiner. Grant probability derived from career allowance rate.